Benzinga Research

Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Screeners

Top Momentum Stocks

Top Quality Stocks

Top Value Stocks

Top Growth Stocks

Comments

Loading...

BioCryst Pharma Stock News

BCRXNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Perks Buy Compare Brokers

Q1 2025 Earnings in 10 days from now on Mon May 5th, before the market open

BioCryst Pharma (BCRX) Forecast

News

Earnings BioCryst Pharma (BCRX) Options Guidance Dividends Analyst Ratings Insider Trades Government Trades Short Interest

Latest BioCryst Pharma Stock News | NASDAQ:BCRX | Benzinga

Get the latest news on BioCryst Pharma stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on BioCryst Pharma performance

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Friday, April 11, 2025

RBC Capital Reiterates Outperform on BioCryst...
Benzinga Newsdesk - Apr 11, 2025, 11:19AM

Thursday, April 10, 2025

Needham Reiterates Buy on BioCryst Pharma, Ma...
Benzinga Newsdesk - Apr 10, 2025, 7:07AM

Tuesday, March 04, 2025

BioCryst Pharmaceuticals' CFO Anthony Doyle N...
Benzinga Newsdesk - Mar 4, 2025, 8:12AM

Monday, March 03, 2025

Citizens Capital Markets Reiterates Market Ou...
Benzinga Newsdesk - Mar 3, 2025, 9:57AM

Tuesday, February 25, 2025

RBC Capital Reiterates Outperform on BioCryst...
Benzinga Newsdesk - Feb 25, 2025, 11:24AM
Citizens Capital Markets Reiterates Market Ou...
Benzinga Newsdesk - Feb 25, 2025, 10:40AM
HC Wainwright & Co. Reiterates Buy on BioCrys...
Benzinga Newsdesk - Feb 25, 2025, 7:58AM

Monday, February 24, 2025

BioCryst Pharmaceuticals Unveils Latest Trial Data, Reports Mixed Q4 Earnings
Vandana Singh - Feb 24, 2025, 11:49AM
BioCryst Pharmaceuticals shares are trading l...
Benzinga Newsdesk - Feb 24, 2025, 10:36AM
Biocryst Pharmaceuticals Expects To Approach ...
Benzinga Newsdesk - Feb 24, 2025, 7:09AM
BioCryst Pharmaceuticals Expects Full Year 20...
Benzinga Newsdesk - Feb 24, 2025, 7:06AM
BioCryst Pharma Q4 2024 Adj EPS $(0.13) Misse...
Benzinga Newsdesk - Feb 24, 2025, 7:02AM
BioCryst Pharmaceuticals Announced Results Fr...
Benzinga Newsdesk - Feb 24, 2025, 6:02AM
Earnings Scheduled For February 24, 2025
Benzinga Insights - Feb 24, 2025, 3:32AM

Wednesday, February 12, 2025

Biocryst PharmaceuticalsS ays Infarmed In Por...
Benzinga Newsdesk - Feb 12, 2025, 7:06AM

Monday, February 10, 2025

Biocryst Pharmaceuticals Announces The Compan...
Benzinga Newsdesk - Feb 10, 2025, 8:33AM

Friday, January 31, 2025

JMP Securities Reiterates Market Outperform o...
Benzinga Newsdesk - Jan 31, 2025, 12:02PM

Monday, January 13, 2025

Evercore ISI Group Maintains Outperform on Bi...
Benzinga Newsdesk - Jan 13, 2025, 10:31AM
Needham Maintains Buy on BioCryst Pharma, Rai...
Benzinga Newsdesk - Jan 13, 2025, 5:34AM

Friday, January 10, 2025

BioCryst Says ORLADEYO Net Revenue Expected B...
Benzinga Newsdesk - Jan 10, 2025, 7:30AM

Monday, November 18, 2024

BioCryst's ORLADEYO Gets Ireland's Approval: ...
Benzinga Newsdesk - Nov 18, 2024, 2:03AM

Tuesday, November 05, 2024

RBC Capital Reiterates Outperform on BioCryst...
Benzinga Newsdesk - Nov 5, 2024, 11:16AM
Needham Reiterates Buy on BioCryst Pharma, Ma...
Benzinga Newsdesk - Nov 5, 2024, 9:50AM
Barclays Maintains Equal-Weight on BioCryst P...
Benzinga Newsdesk - Nov 5, 2024, 8:40AM

Monday, November 04, 2024

12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights - Nov 4, 2024, 11:40AM
BioCryst Pharma shares are trading lower foll...
Benzinga Newsdesk - Nov 4, 2024, 9:01AM
BioCryst Adjusts ORLADEYO Revenue Guidance To...
Benzinga Newsdesk - Nov 4, 2024, 7:03AM
BioCryst Pharma Q3 2024 GAAP EPS $(0.07) Miss...
Benzinga Newsdesk - Nov 4, 2024, 7:01AM

Thursday, October 24, 2024

BioCryst Highlights Real-World Data Showing H...
Benzinga Newsdesk - Oct 24, 2024, 8:04AM

Monday, October 14, 2024

BioCryst's ORLADEYO Reduces Hospital Visits a...
Benzinga Newsdesk - Oct 14, 2024, 7:08AM

Wednesday, October 02, 2024

BioCryst Pharmaceuticals Has Enrolled The Fir...
Benzinga Newsdesk - Oct 2, 2024, 7:04AM

Monday, September 30, 2024

The Us Department Of Health And Human Service...
Benzinga Newsdesk - Sep 30, 2024, 7:04AM

Tuesday, September 17, 2024

BioCryst Pharmaceuticals Has Completed Negoti...
Benzinga Newsdesk - Sep 17, 2024, 7:12AM

Friday, September 06, 2024

BioCryst Presents Results on HAE Treatment an...
Benzinga Newsdesk - Sep 6, 2024, 3:02AM

Tuesday, August 06, 2024

JMP Securities Maintains Market Outperform on...
Benzinga Newsdesk - Aug 6, 2024, 1:04PM
Barclays Maintains Equal-Weight on BioCryst P...
Benzinga Newsdesk - Aug 6, 2024, 8:53AM
RBC Capital Reiterates Outperform on BioCryst...
Benzinga Newsdesk - Aug 6, 2024, 8:34AM
HC Wainwright & Co. Reiterates Buy on BioCrys...
Benzinga Newsdesk - Aug 6, 2024, 6:30AM

Monday, August 05, 2024

BioCryst Pharmaceuticals shares are trading h...
Benzinga Newsdesk - Aug 5, 2024, 2:34PM
BioCryst Pharmaceuticals Says It Expects To A...
Benzinga Newsdesk - Aug 5, 2024, 7:07AM
BioCryst Pharmaceuticals Has Raised Its 2024 ...
Benzinga Newsdesk - Aug 5, 2024, 7:05AM
BioCryst Pharma Q2 2024 GAAP EPS $(0.06) Beat...
Benzinga Newsdesk - Aug 5, 2024, 7:02AM

Sunday, June 02, 2024

BioCryst Announced Data Showing Reductions In Attack Rates In HAE Patients with Normal C1-Inhibitor After Beginning ORLADEYO Treatment
Charles Gross - Jun 2, 2024, 10:46AM

Wednesday, May 15, 2024

Why Bolt Biotherapeutics Shares Are Trading Lower By Around 34%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Avi Kapoor - May 15, 2024, 1:38PM
BioCryst Pharmaceuticals Form 4 Filings Shows...
Benzinga Newsdesk - May 15, 2024, 12:26PM
NEXTracker Posts Upbeat Earnings, Joins monday.com, Nu Holdings And Other Big Stocks Moving Higher On Wednesday
Avi Kapoor - May 15, 2024, 10:21AM

Thursday, May 09, 2024

BioCryst Presents New Real-world Evidence Sho...
Benzinga Newsdesk - May 9, 2024, 7:41AM

Tuesday, May 07, 2024

JMP Securities Maintains Market Outperform on...
Benzinga Newsdesk - May 7, 2024, 11:29AM
HC Wainwright & Co. Reiterates Buy on BioCrys...
Benzinga Newsdesk - May 7, 2024, 6:16AM
Needham Reiterates Buy on BioCryst Pharma, Ma...
Benzinga Newsdesk - May 7, 2024, 5:33AM

Create a Watchlist

FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.

People Also Watch

Connect With Us

About Benzinga

About Us
Careers
Advertise
Contact Us

Market Resources

Advanced Stock Screener Tools
Options Trading Chain Analysis
Comprehensive Earnings Calendar
Dividend Investor Calendar and Alerts
Economic Calendar and Market Events
IPO Calendar and New Listings
Market Outlook and Analysis
Wall Street Analyst Ratings and Targets

Trading Tools & Education

Benzinga Pro Trading Platform
Options Trading Strategies and News
Stock Market Trading Ideas and Analysis
Technical Analysis Charts and Indicators
Fundamental Analysis and Valuation
Day Trading Guides and Strategies
Live Investors Events
Pre market Stock Analysis and News
Cryptocurrency Market Analysis and News

Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2025 Benzinga | All Rights Reserved